Navigation Links
Halozyme Reports First Quarter 2012 Financial Results
Date:5/7/2012

statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including unexpected expenditures, clinical trial results, delays in development and regulatory review, regulatory approval requirements and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the Company's reports on Forms 10-K, 10-Q, and other filings with the Securities and Exchange Commission.

Media/Investor Contact:
Anne Erickson
Executive Director
Halozyme Therapeutics
858-704-8264
aerickson@halozyme.com Halozyme Therapeutics, Inc.Unaudited Condensed Consolidated Statements of OperationsThree Months Ended March 31,20122011REVENUES:Product sales, net

$
87,411$165,449Revenues under collaborative agreements

7,252,7687,378,445Total revenues

7,440,1797,543,894OPERATING EXPENSES:Cost of product sales

70,76111,717Research and development

15,891,10913,785,797Selling, general and administrative

6,618,7073,405,966Total operating expenses

22,580,57717,203,480OPERATING LOSS

(15,140,398)(9,659,586)Interest and other income, net

21,21723,869NET LOSS

$  (15,119,181)$ (9,635,717)Basic and diluted net loss per share

$
(0.14)$
(0.10)Shares used in computing basic and diluted net loss per share

107,589,514100,927,402 Halozyme Therapeutics, Inc.Unaudited Condensed Consolidated Balance SheetsMarch 31,December 31,20122011ASSETSCurrent assets:Cash and cash equivalents

$
,608,304$
52,825,527Account
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Halozyme to Host First Quarter 2012 Financial Results Conference Call
2. ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20)
3. Halozyme Therapeutics to Present at the CITI 2012 Global Healthcare Conference
4. Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock
5. Halozyme Announces Proposed Public Offering of Common Stock
6. ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
7. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
8. Halozyme Therapeutics to Present Data on PEGPH20 at the Upcoming 2011 EORTC-NCI-ASCO Annual Meeting
9. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
10. Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer
11. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015  The onset of puberty can make young athletes ... and thus more inclined toward a variety of injuries. ... body,s center of gravity is altered. It,s a period of ... quickly than the rest of the body and, in some ... year. And while these sudden changes are a natural part ...
(Date:3/6/2015)... 2015   Hospira, Inc. (NYSE: HSP ... (FDA) on today,s FDA approval of the first biosimilar in ... watershed moment for improving patient access to safe, effective and ... biosimilars, Hospira has seen first-hand the positive impact of biosimilars ... these early stages of the development of a pathway for ...
(Date:3/6/2015)... Washington , 6. März 2015 /PRNewswire/ ... von Röntgenstrahlen, feierte auf dem European Congress ... , Österreich, die 1.000. Installation seines ... Logo - http://photos.prnewswire.com/prnh/20150304/179432LOGO ... Dosimeter, der in Echtzeit Informationen über die ...
Breaking Medicine Technology:Puberty can result in variety of athletic injuries 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Unfors RaySafe, ein Unternehmen von Fluke Biomedical, feiert 1.000. Installation seines Systems zur Echtzeit-Strahlendosimetrie 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, feiert 1.000. Installation seines Systems zur Echtzeit-Strahlendosimetrie 3
... Pharmaceuticals, Inc. today announced that Marsha Fanucci has joined ... Pharmaceuticals, Inc. from 2000-2009 in a number of senior ... of strategy, vice president of finance and strategy, and ... tenure as CFO, Ms. Fanucci led Millennium through a ...
... , PARIS, Oct. 27 Diabetic patients diagnosed ... reduced use of anticonvulsant medications when treated with ... presented today at the International Society for Pharmacoeconomics ... The results of the HealthCore, Inc. study, funded ...
Cached Medicine Technology:Marsha Fanucci Joins Ironwood Board of Directors 2Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR 2Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR 3
(Date:3/6/2015)... 07, 2015 Protein identification is ... production, life science research including drug discovery, diagnostics, ... characterization market was valued at $1,569.00 million in ... CAGR of 10.63% to reach $2,600.28 million in ... characterization of protein based on protein size, shape, ...
(Date:3/6/2015)... Sanjay Gupta, MD, CNN’s Emmy award-winning ... at ATA 2015, the American Telemedicine Association's (ATA) ... world’s largest telemedicine, telehealth and mHealth meeting. , ... for several of CNN’s headlining programs including New ... DuPont Award winning WEED series. He has created ...
(Date:3/6/2015)... March 06, 2015 Ticket Down is a ... Oregon at the Moda Center. After being away ... Brooks is showing no signs of letting up on his ... legend and his wife, Trisha Yearwood, to venues around the ... bringing their critically acclaimed tour to the Moda Center in ...
(Date:3/6/2015)... NY (PRWEB) March 06, 2015 Ticket Down ... . This popular ticket exchange has extended their customer appreciation ... from Hebden Bridge, West Yorkshire England and he began his ... In the past couple of years Ed Sheeran has ... whenever Ed Sheeran is on stage he is having the ...
(Date:3/6/2015)... March 06, 2015 At Natural ... announced today the launch of its powerful, location-aware ... healthy and sustainable products at any retailer that ... exhibiting at Expo West Booth 6054. , ... gluten-free, Kosher, non-GMO, organic, Paleo, and vegan, among ...
Breaking Medicine News(10 mins):Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 2Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 3Health News:CNN’s Dr. Sanjay Gupta Among Headliners at American Telemedicine Association 2015 Annual Meeting 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:Ed Sheeran Tickets in Indianapolis, Austin, Albany, St. Louis, London, Des Moines, Salt Lake City, Saskatoon, Regina and Denver/Morrison Now On Sale at Ticket Down 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3
... Morbidity and Mortality Weekly Report released by the U.S. Centers ... Down's syndrome are the leading birth defects in the country.// ... conditions so we can understand the import they have on ... perinatal data center at the March of Dimes Birth Defects ...
... an accusatory report by a consumer group UK supermarkets ... ,The claims made by the group include that ... in pre-packaged sandwiches with a combination of water, starch ... artificial flavorings. ,The results came after a ...
... Ramadoss as assured the radiologist during the 59th Annual ... at Chennai that the current 12% tax on radiology// ... diagnostic equipment in Government hospitals will be repaired and ... up in all Government hospitals which would aid in ...
... in the crown of physical exercisers. A new study in ... wound-healing process by as much as 25 percent//. ... will become infected. ,The results appear in a ... ,This is the first time such an enhancement associated ...
... Health has announced that the number of AIDS-related deaths in the ... Thailand's The Nation//. ,The health ministry's Disease Control ... in the number of new HIV cases in to about 18,000 ... who developed AIDS dwindled from 13,364 in 2004 to 8,681 in ...
... men, and this may be due to genetic factors, according ... In the January issue of the journal, researchers reported that ... men, where it is approximately 29%. ,"Our ... represents the largest epidemiological study of depression in twins done ...
Cached Medicine News:Health News:Wounds Heal 25% Faster In Older Adults Who Exercise Regularly 2Health News:Wounds Heal 25% Faster In Older Adults Who Exercise Regularly 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: